Date] STRICTLY PERSONAL AND CONFIDENTIAL [Name] [Address] Dear [Name]: Re: Amendments to your Employment AgreementNovelion Therapeutics Inc. • May 9th, 2017 • Pharmaceutical preparations
Further to our recent discussions, this letter sets out our proposal to amend the terms your employment with Novelion Services USA, Inc. (“Novelion Services”). This letter is referred to as the Amendment Agreement.
AMENDED AND RESTATED SUPPLEMENTAL INDENTURESupplemental Indenture • May 9th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • New York
This Amended and Restated Supplemental Indenture (this “Restated Supplemental Indenture”) is dated as of May 8, 2017, by and among Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Novelion Therapeutics Inc. (f/k/a QLT Inc.), a British Columbia corporation (“Novelion”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as Trustee (the “Trustee”), and amends and restates in its entirety that certain Supplemental Indenture (the “Supplemental Indenture”), dated as of November 29, 2016, by and between the Company and the Trustee.
EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”) is made and entered into as of this 8th day of May, 2017, by and between (1) Novelion Services USA, Inc., a Delaware corporation (the “Company”) and, solely with respect to Sections 2, 9(a) and 12 hereof, Aegerion Pharmaceuticals, Inc. (“Aegerion”), on the one hand, and (2) Mary T. Szela (the “Employee”), on the other hand.
